Peloid Therapy in Temporomandibular Joint Dysfunction
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUşak University
About this trial
This prospective, single-group clinical study will evaluate whether local peloid therapy improves pain and jaw function in adults with temporomandibular joint dysfunction. Participants will receive peloid therapy applied to the temporomandibular joint region and masticatory muscles for 20 minutes per session, 5 days per week, for 2 weeks. Pain and functional outcomes will be measured at baseline and at the end of treatment using validated clinical scales, including the Jaw Functional Limitation Scale-8, visual analog scale pain scores, Fonseca index, maximum mouth opening, and secondary otalgia assessment.
Eligibility criteria
Qualifiers
Age between 18 and 65 years
Diagnosis of temporomandibular joint dysfunction based on DC/TMD criteria
Presence of TMJ-related pain for at least 4 weeks
Baseline pain intensity ≥3 on a 0-10 visual analog scale
Disqualifiers
History of temporomandibular joint trauma, tumor, active infection, or acute inflammation
Previous temporomandibular joint surgery
Presence of systemic inflammatory rheumatologic disease
Pregnancy
Trial design
Treatments tested in this trial
- Local Peloid Therapy
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov